Previous studies have shown that the serum levels of adiponectin are reduced in NASH patients (31), and hypoadiponectinemia is negatively associated with steatosis and inflammation in NAFLD patients (32). The gene discussed is ADIPOQ; the disease is adiponectin deficiency.